SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-11-000239
Filing Date
2011-02-14
Accepted
2011-02-14 19:03:36
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT adamis-10q_0204.htm 10-Q 533447
2 PRODUCT DEVELOPMENT AND CONTRACT MANUFACTURING AGREEMENT ex10_16.htm EX-10.16 351646
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 19394
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 20184
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 8522
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 8404
  Complete submission text file 0001387131-11-000239.txt   943201
Mailing Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014
Business Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014 (858) 401-3984
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-26372 | Film No.: 11610163
SIC: 2834 Pharmaceutical Preparations